Concepedia

Publication | Open Access

A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids

15

Citations

24

References

2020

Year

Abstract

GSK study ID: 205832; Clinicaltrials.gov ID: NCT03012061.

References

YearCitations

Page 1